Germany · Delayed Price · Currency is EUR JOST Werke SE Earnings Call Transcripts
Fiscal Year 2026
-
Record Q1 sales and EBIT driven by strong organic growth and successful Hyva integration. All regions contributed, with notable gains in agriculture and APAC. Guidance for 2026 is confirmed, with cautious optimism amid geopolitical risks.
Fiscal Year 2025
-
Strong 2025 growth was achieved through Hyva integration and organic gains, with sales up 44% and Adjusted EBIT up 29%. Despite weak markets, all regions contributed, and 2026 guidance targets further margin and earnings growth, with robust order intake and ongoing M&A focus.
-
Q3 2025 saw strong sales and profit growth, driven by Hyva integration and organic gains across all regions, despite weak U.S. markets. Synergies and cash flow improved, leverage targets were met early, and guidance for 2025 is confirmed at the lower to mid range.
-
Q2 2025 saw 31% sales growth driven by the Hyva acquisition, with strong performance in EMEA and APAC, and resilience despite US market weakness. The outlook for 2025 is confirmed, with expected sales up 40–50% and adjusted EBIT up 23–28% year-over-year.
-
Q1 2025 saw a 25% sales increase and strong cash flow, driven by the Hyva acquisition and robust aftermarket demand, despite organic sales declines. Integration is on track, with EUR 27 million in synergies identified and full-year guidance confirmed.
Fiscal Year 2024
-
Despite a challenging market, sales and EBIT declined but margins and cash flow remained strong, aided by M&A and cost control. The Hyva acquisition will drive significant growth and synergies in 2025, with markets expected to bottom out and a more balanced regional and product mix supporting resilience.
-
Q3 2024 was marked by weak markets and a 20% organic sales decline, but profitability remained resilient with a 10.8% EBIT margin and strong free cash flow. The Hyva acquisition and operational consolidations position the group for future growth, with recovery in key segments expected in 2025.
-
The acquisition of Hyva is set to expand the branded product portfolio, strengthen global market presence, and balance exposure between on- and off-highway sectors. Synergies in purchasing, logistics, and SG&A are expected to drive margin improvements and value creation within two years.
-
Ambitious 2030 targets include over €2 billion in sales, €10 EPS, and a 10–12% EBIT margin, driven by equal parts organic and inorganic growth. Strategic focus is on expanding agriculture/off-highway, technology leadership, disciplined M&A, and operational excellence, with strong ESG and capital efficiency commitments.
-
Two strategic acquisitions and a new plant in India will expand the agricultural business, adding €100 million in annual revenues and increasing the segment's share to 28-29% of total sales. The moves strengthen global market presence, diversify the product mix, and are expected to deliver significant synergies and profitable growth.
-
Q2 2024 saw resilient profitability with an 11.3% EBIT margin despite a 10% sales decline, strong free cash flow, and robust performance in North America and premium product segments. Strategic R&D investment and disciplined cost management support a stable outlook for 2024.